| Literature DB >> 34345363 |
Wafik Mahmoud El-Sheik1, Aktham Ismail El-Emam1, Ahmed Abd El-Galil Abd El-Rahman2, Gelan Mahmoud Salim1.
Abstract
Various mechanisms contribute to dementia after first ischemic stroke as lesions on strategic areas of cognition and stroke premorbidity.Entities:
Keywords: dementia; strategic infarction; stroke
Year: 2021 PMID: 34345363 PMCID: PMC8283871 DOI: 10.1590/1980-57642021dn15-020009
Source DB: PubMed Journal: Dement Neuropsychol ISSN: 1980-5764
Demographic and clinical characteristics of first stoke patients with and without dementia.
| Sociodemographic | First ischemic stroke patients | Test | p-value | |||
|---|---|---|---|---|---|---|
|
I=dementia (n=40) |
II=non-demented (n=40) | |||||
| Age/year X±SD | 60.7±8.73 | 57.70±5.69 | t-test | |||
| Range | 41-79 | 50-74 | 1.62 | 0.11 | ||
| No | % | No | % | chi-square test | ||
| Sex Male | 31 | 77.5 | 25 | 62.5 | 2.14 | 0.14 |
| Female | 9 | 22.5 | 15 | 37.5 | ||
| DM Positive | 27 | 67.5 | 11 | 27.5 | FE | <0.001 |
| Negative | 13 | 32.5 | 29 | 72.5 | 12.83 | |
| HTN Positive | 26 | 65.0 | 17 | 42.5 | 4.07 | 0.04 |
| Negative | 14 | 35.0 | 23 | 57.5 | ||
| Smoking Smoker | 25 | 62.5 | 13 | 32.5 | ||
| Non-smoker | 15 | 37.5 | 27 | 67.5 | 7.22 | 0.01 |
| IHD Positive | 15 | 37.5 | 3 | 7.5 | 10.32 | 0.001 |
| Negative | 25 | 62.5 | 37 | 92.5 | ||
| AF Positive | 3 | 7.5 | 2 | 5.0 | FE | 1.0 |
| Negative | 37 | 92.5 | 38 | 95.0 | 0.21 | |
| Lipid profile | ||||||
| Normal | 3 | 7.5 | 10 | 25.0 | 4.50 | 0.03 |
| Dyslipidemia | 37 | 92.5 | 30 | 75.0 | S | |
| NIH Stroke Scale | ||||||
| X±SD | 6.70±3.55 | 4.90±3.12 | U test | 0.02 | ||
| Range | 2-18 | 0-12 | 2.42 | |||
X: mean; SD: standard deviation; FE: Fisher's exact test; p-value<0.05=significant; NIH: National Institute Health.
Figure 1.National Institute Health Stroke Scale among patients and controls.
Montreal Cognitive Assessment of first stroke patients with post stroke dementia and these without post stroke dementia.
| MoCA items | First stroke patients | Statistical analysis | ||
|---|---|---|---|---|
|
Dementia n=40 |
Non-demented n=40 | U | p-value | |
| Executive functions X±SD | 3.65±1.03 | 4.70±0.72 | ||
| Range | 2-5 | 3-5 | 5.15 | <0.001 |
| Naming X±SD | 1.80±0.76 | 2.9±0.30 | ||
| Range | 1-3 | 2-3 | 6.33 | <0.001 |
| Memory X±SD | 3.4±1.26 | 4.6±0.74 | ||
| Range | 1-5 | 3-5 | 4.77 | <0.001 |
| Language X±SD | 2.1±0.30 | 2.85±0.36 | ||
| Range | 2-3 | 2-3 | 6.67 | <0.001 |
| Attention X±SD | 4.60±0.87 | 5.55±0.60 | ||
| Range | 3-6 | 4-6 | 4.84 | <0.001 |
| Abstraction X±SD | 1.85±0.36 | 1.95±0.22 | ||
| Range | 1-2 | 1-2 | 1.48 | 0.14 |
| Orientation X±SD | 5.45±1.13 | 5.75±0.54 | ||
| Range | 2-6 | 4-6 | 0.77 | 0.44 |
| Total MoCA X±SD | 22.90±2.54 | 28.40±1.30 | ||
| Range | 16-25 | 26-30 | 7.76 | <0.001 |
MoCA: Montreal Cognitive Assessment; X: mean; SD: standard deviation; U: Mann Whitney U test; p<0.001; HS: highly significant; p>0.05=non-significant.
Figure 2.Relationship between Trial of ORG 10172 in Acute Stroke Treatment classification (atiology) and both Montreal Cognitive Assessment scale and National Institute Health Stroke Scale.
Site and cause of stroke (magnetic resonance imaging brain and TOAST classification).
| MRI report | The studied groups | Test | p-value | |||
|---|---|---|---|---|---|---|
|
Dementia n=40 |
Non-demented n=40 | |||||
| No | % | No | % | chi-square | ||
| Side of the lesion | ||||||
| Right | 14 | 35.0 | 23 | 57.5 | 4.07 | 0.04 |
| Left | 26 | 65.0 | 17 | 42.5 | ||
| Location of infarction | Z test | |||||
| Strategic areas | 30 | 75 | 11 | 27.5 | 4.03 | <0.001 |
|
-Thalamic -Basal ganglia -Angular gyrus -Hippocampus |
10 8 3 9 |
25.0 20.0 7.5 22.5 |
4 2 1 4 |
10.0 5.0 2.5 10.0 |
1.47 1.69 0.51 1.21 |
0.07 0.04 0.30 0.11 |
| Non-strategic areas | 10 | 25.0 | 29 | 72.5 | 4.03 | <0.001 |
| Affected circulation | ||||||
| Anterior |
| 85.0 | 22 | 55.0 | 8.57 | 0.003 |
| Posterior |
| 15.0 | 18 | 45.0 | ||
| TOAST classification | ||||||
| LV | 18 | 45.0 | 7 | 17.5 | 8.96 | 0.01 |
| SV | 18 | 45.0 | 31 | 77.5 | ||
| CE | 4 | 10.0 | 2 | 5.0 | ||
TOAST: Trial of ORG 10172 in Acute Stroke Treatment; LV : large vessel; SV: small vessel; CE: cardioembolic.
Binary logistic regression analysis for independent risk factors of dementia among stroke patients.
| Risk factors | SE | Wald chi-square test | p-value |
|
95%CI (lower‒upper) |
|---|---|---|---|---|---|
| DM | 0.02 | 2.54 | 0.02 | 1.88 | 1.44-4.55 |
| HTN | 0.67 | 0.67 | 0.89 | 0.87 | 0.23-2.06 |
| Smoking | 1.02 | 1.43 | 0.13 | 1.12 | 0.65-3.44 |
| IHD | 0.33 | 0.97 | 0.34 | 0.95 | 0.12-2.33 |
| Lipid profile | 0.56 | 0.56 | 0.65 | 1.01 | 0.76-5.66 |
| NIH Stroke Scale | 2.30 | 1.26 | 0.17 | 1.21 | 0.99-3.45 |
| TOAST classification | 1.87 | 0.89 | 0.33 | 0.96 | 0.76-5.01 |
| Left side of lesion | 0.22 | 2.54 | 0.01 | 3.09 | 1.67-10.3 |
| Strategic area affection | 2.22 | 2.44 | 0.02 | 2.33 | 1.87-8.77 |
| Anterior circulation affection | 1.98 | 2.65 | 0.01 | 1.86 | 1.45-6.54 |
SE: standard error; 95%CI: 95% confidence interval; DM: diabetes mellitus; HTN: hypertension; IHD: ischemic heart disease; NIH: National Institute Health; TOAST: Trial of ORG 10172 in Acute Stroke Treatment.